Publication date: Feb 04, 2025
To evaluate whether hypofractionated radiotherapy (HF-RT) in node-negative intact breast cancer significantly increased after guideline updates, trial publications, and COVID-19. Patients with node-negative breast cancer undergoing lumpectomy and adjuvant RT were identified in the National Cancer Database. Receiving ≥25 and 20 fractions defined conventional RT (CF-RT). Patient characteristics were compared with X2 testing. Joinpoint analysis identified when fractionation significantly changed. Variables associated with HF-RT were identified by univariate and multivariate (MVA) logistic regression. Two-sided P-value
| Concepts | Keywords |
|---|---|
| Cancer | Breast |
| Covid | Cancer |
| Database | Clinical |
| Radiotherapy | Consensus |
| Covid | |
| Fractionation | |
| Guidelines | |
| Hf | |
| Identified | |
| Intact | |
| Negative | |
| Node | |
| Practices | |
| Rt | |
| Trials |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Breast Cancer |
| pathway | KEGG | Breast cancer |
| disease | MESH | Cancer |
Original Article
(Visited 1 times, 1 visits today)